Form D · Pharmaceuticals
HUMANIGEN, INC
Burlingame, CA · CIK 0001293310
Offering snapshot reported Nov 22, 2019 · SEC filing
- Reported sold
- $495K Offering amount: $20.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 8, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 22, 2019 | Initial | $494,614 | No comparison | 1 | SEC filing |
| May 7, 2019 | Initial | $1,300,000 | No comparison | 11 | SEC filing |
| Sep 5, 2017 | Initial | $15,000 | No comparison | 1 | SEC filing |
| Jul 15, 2016 | Initial | $12,150,000 | No comparison | 8 | SEC filing |
| Jan 6, 2016 | Initial | $8,218,000 | No comparison | 18 | SEC filing |
| May 21, 2012 | Initial | $17,000,000 | No comparison | 8 | SEC filing |
| Oct 6, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 2, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-354085
Amounts include common stock issued or issuable to Lincoln Park Capital Fund, LLC ("Lincoln Park") pursuant to the purchase agreement dated November 8, 2019 by and between Humanigen, Inc. and Lincoln Park.
Source: Form D, filed Nov 22, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ronald Barliant | Director |
| Rainer Boehm | Director |
| Dale Chappell | Director |
| Cameron Durrant | Director, Executive |
| Ezra Friedberg | Director |
| Denise Gilbert | Director |
| Michael Harrison | Director |
| James Healy | Director |
| Dennis Henner | Director |
| Greg Jester | Executive |
| Jeanne Jew | Executive |
| Morgan Lam | Executive |
| Ted Love | Director |
| Gary Lyons | Director |
| David Moradi | Director |
| Timothy Morris | Director |
| David Pritchard | Director, Executive |
| Robert Savage | Director |
| Brigitte Smith | Director |
| Ray Withy | Director |
| Dean Witter Iii | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
533 Airport Blvd. Suite 400
Burlingame, CA, 94010
Burlingame, CA, 94010